University of California Video Podcasts (Video)

America is more politically polarized now than at almost any other time in our history. Dean Henry E. Brady of UC Berkeley's Goldman School of Public Policy is studying that polarization and what, if anything, can be done to reverse it. He explains how changing political priorities, technology, and partisan media have all played a role in bringing us to a point where Republicans and Democrats don't even want their children to marry people from the other party. Series: "UC Public Policy Channel" [Public Affairs] [Show ID: 35618]

Bianca Valenti is a professional big-wave surfer, business innovator, and environmental activist. Valenti is leading movements focused on pay equity and growth opportunity in sport. Series: "Innovator Stories: Creating Something from Nothing" [Business] [Show ID: 36440]

At 28, Sandra Dillon was diagnosed with myelofibrosis, a life-threatening blood disorder that can lead to acute leukemia. After participating in clinical trials and cutting edge treatments, Dillon has a deep appreciation for personalized medicine and genomics. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36357]

This lecture opens with the breaking news of Trump’s COVID-19 diagnosis and the super spreader event that broke out in the White House last week. From there we turn to a detailed discussion of social movements, organizing and democracy. Professor Jayaraman discusses the question of power, the elements and goals of organizing, the dynamics of social movements, and the cycles of contention through which social movements grow. She argues that the more people engage in contentious action over a sustained period of time, the more transformative change becomes possible. The discussion concludes with an analysis of how social movements can map power relations and best run campaigns to change public policy. Series: "UC Public Policy Channel" [Public Affairs] [Show ID: 36283]

Experts share perspectives on institutional, state and national efforts to create knowledge networks that accelerate bench top research, clinical trials, and patient access to experimental and approved therapies. A discussion of how best to capture and integrate various datasets to improve understanding of diseases, discovery of novel targets, therapeutic candidates and biomarkers, accelerating clinical development and approval of novel therapies and enhancing patient access and affordability. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36337]

Stem cell research is providing hope for new therapies to treat neurodegenerative diseases. Hear from those on the front lines about what is next.

Moderated by Clive Svendsen, PhD, Cedars-Sinai

HD Care: Patient Support Perspective

Ralph Kern MD MHSc, Brainstorm Cell Therapeutics: NurOwn (autologous MSC-NTF cells) in ALS- phase 3 clinical trial update

Jeanne F. Loring, PhD, Aspen Neuroscience: Neuron replacement therapy for Parkinsons disease

Leslie Thompson, PhD, UCI: Stem Cell Based Therapy for Huntington's Disease Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36323]

Dr. Nadine Burke Harris, California's first-ever Surgeon General , is dedicated to changing the way our society deals with the public health crisis of childhood trauma. An overwhelming scientific consensus demonstrates that cumulative adversity, particularly during critical and sensitive developmental periods, is a root cause to some of the most harmful, persistent and expensive health challenges facing our nation. In this keynote address at the 2020 CIRM Grantee Meeting, Dr. Burke Harris explains the science and solutions. Series: "Women in Science" [Health and Medicine] [Show ID: 36328]

Can we discover new therapies for the heart with stem cells? From finding safer medication to preventing cardiac arrest, experts share the latest in the field of cardiac stem cell research.

Moderated by Anthony DeMaria, MD, UC San Diego

Pat Farrant: Patient Perspective

Deepak Srivastava, MD, Gladstone Institutes: Cellular Reprogramming Approaches for Heart Disease

Mark Mercola, PhD, Stanford University: Induced Pluripotent Stem Cell (iPSC)-derived Cardiomyocytes for Predicting and Removing Drug Cardiotoxicity

Deborah K. Lieu, PhD, UC Davis: The quest for pacemaking cardiomyocytes to engineer biopacemakers Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36336]

What can we learn about COVID-19 through stem cell research? A panel of experts shares what we know and what may be possible.

Moderated by Evan Snyder, MD, PhD, Sanford-Burnham Medical Research Institute

Brigitte Gomperts, MD, UCLA: Using Lung Stem Cells to Study the Effects of Cigarette Smoking on COVID-19

Sandra Leibel, MD MSc, UC San Diego: Addressing disparity in COVID-19 lung disease & therapeutic response using patient-specific hiPSC-derived lung organoids

Justin Ichida, PhD, USC: Development of a new drug to prevent coronavirus infection

Karen L. Christman, PhD, UC San Diego: Pro-healing biomaterial for treating inflammation

Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36343]

Robert A.J. Signer, PhD

UC San Diego Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36359]